PLoS ONE · 2011 · 101 citations · 24 references
Signal TransducersDermatologyCell GrowthTumor BiologyTranscriptional RegulationSignaling PathwayReceptor Tyrosine KinaseFibroblast Growth FactorCell SignalingMolecular SignalingStat ProteinsG Protein-coupled ReceptorReceptor (Biochemistry)Cell BiologyTumor MicroenvironmentSignal TransductionAberrant Egfr SignalingCellular BiochemistrySystems BiologyMedicine
Signaling mediated by the Epidermal Growth Factor Receptor (EGFR) is crucial in normal development, and aberrant EGFR signaling has been implicated in a wide variety of cancers. Here we find that the high- and low-affinity interactions between EGFR and its ligands activate different signaling pathways. While high-affinity ligand binding is sufficient for activation of most canonical signaling pathways, low-affinity binding is required for the activation of the Signal transducers and activators of transcription (Stats) and Phospholipase C-gamma 1 (PLCγ1). As the Stat proteins are involved in many cellular responses including proliferation, migration and apoptosis, these results assign a function to low-affinity interactions that has been omitted from computational models of EGFR signaling. The existence of receptors with distinct signaling properties provides a way for EGFR to respond to different concentrations of the same ligand in qualitatively different ways.
24
A comprehensive pathway map of epidermal growth factor receptor signaling
Kanae Oda, Yukiko Matsuoka, Akira Funahashi et al. · Molecular Systems Biology · 2005 · 1.2K citations · Full text
Harry T. Haigler, J. F. Ash, Sherwin J. Singer et al. · Proceedings of the National Academy of Sciences · 1978 · 575 citations · Full text
Fluorescent Vesicles, Epidermal Growth Factor, Extracellular Microvesicles +18